The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer

  1. Lee, J.W.
  2. Zhang, Y.
  3. Eoh, K.J.
  4. Sharma, R.
  5. Sanmamed, M.F.
  6. Wu, J.
  7. Choi, J.
  8. Park, H.S.
  9. Iwasaki, A.
  10. Kaftan, E.
  11. Chen, L.
  12. Papadimitrakopoulou, V.
  13. Herbst, R.S.
  14. Koo, J.S.
Revue:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Année de publication: 2019

Volumen: 14

Número: 6

Pages: 1046-1060

Type: Article

DOI: 10.1016/J.JTHO.2019.02.004 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus